Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus-Cost effectiveness of outpatient treatment.

Saved in:
Bibliographic Details
Title: Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus-Cost effectiveness of outpatient treatment.
Authors: Rentinck MN; Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Krüger R; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Division of Pulmonology, Immunology and Critical Care Medicine, Department of Pediatrics, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Hoppe PA; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Division of Pulmonology, Immunology and Critical Care Medicine, Department of Pediatrics, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Humme D; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Department of Dermatology, Venerology and Allergology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Niebank M; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Pokrywka A; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Department of Dermatology, Venerology and Allergology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Stegemann M; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Kola A; Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Hanitsch LG; Institute of Medical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Leistner R; Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Division of Gastroenterology, Infectious Diseases and Rheumatology (including Nutritional Medicine), Medical Department, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Source: PloS one [PLoS One] 2021 Jun 25; Vol. 16 (6), pp. e0253633. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34170945
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus-Cost effectiveness of outpatient treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rentinck+MN%22">Rentinck MN</searchLink>; Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Krüger+R%22">Krüger R</searchLink>; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Division of Pulmonology, Immunology and Critical Care Medicine, Department of Pediatrics, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hoppe+PA%22">Hoppe PA</searchLink>; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Division of Pulmonology, Immunology and Critical Care Medicine, Department of Pediatrics, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Humme+D%22">Humme D</searchLink>; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Department of Dermatology, Venerology and Allergology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Niebank+M%22">Niebank M</searchLink>; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Pokrywka+A%22">Pokrywka A</searchLink>; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Department of Dermatology, Venerology and Allergology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Stegemann+M%22">Stegemann M</searchLink>; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kola+A%22">Kola A</searchLink>; Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hanitsch+LG%22">Hanitsch LG</searchLink>; Institute of Medical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Leistner+R%22">Leistner R</searchLink>; Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.; Division of Gastroenterology, Infectious Diseases and Rheumatology (including Nutritional Medicine), Medical Department, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2021 Jun 25; Vol. 16 (6), pp. e0253633. <i>Date of Electronic Publication: </i>2021 Jun 25 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34170945
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0253633
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0253633
    Titles:
      – TitleFull: Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus-Cost effectiveness of outpatient treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rentinck MN
      – PersonEntity:
          Name:
            NameFull: Krüger R
      – PersonEntity:
          Name:
            NameFull: Hoppe PA
      – PersonEntity:
          Name:
            NameFull: Humme D
      – PersonEntity:
          Name:
            NameFull: Niebank M
      – PersonEntity:
          Name:
            NameFull: Pokrywka A
      – PersonEntity:
          Name:
            NameFull: Stegemann M
      – PersonEntity:
          Name:
            NameFull: Kola A
      – PersonEntity:
          Name:
            NameFull: Hanitsch LG
      – PersonEntity:
          Name:
            NameFull: Leistner R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 06
              Text: 2021 Jun 25
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1